- Home
- BFRI vs SCNX Comparison
BFRI vs SCNX Comparison
Compare BFRI & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BFRI | SCNX |
|---|---|---|
| Founded | 1997 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.3M | 15.5M |
| IPO Year | 2021 | 2019 |
Fundamental Metrics
Financial Performance| Metric | BFRI | SCNX |
|---|---|---|
| Price | $1.42 | $0.43 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $2.75 | $1.50 |
| AVG Volume (30 Days) | 537.6K | ★ 704.0K |
| Earning Date | 05-13-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 67.70 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,705,000.00 | $3,831,778.00 |
| Revenue This Year | $14.36 | $1,097.38 |
| Revenue Next Year | $16.98 | $239.80 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 11.75 | ★ 30.72 |
| 52 Week Low | $0.57 | $0.24 |
| 52 Week High | $1.52 | $2.60 |
Technical Indicators
Market Signals| Indicator | BFRI | SCNX |
|---|---|---|
| Relative Strength Index (RSI) | 70.12 | 50.94 |
| Support Level | $0.77 | $0.37 |
| Resistance Level | N/A | $0.43 |
| Average True Range (ATR) | 0.09 | 0.04 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 71.62 | 49.05 |
Price Performance
Historical ComparisonAbout BFRI Biofrontera Inc.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions. The company's revenues are derived from within the United States and, therefore, no other geographical segments.
About SCNX Scienture Holdings Inc.
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on the commercialization and development of products for the treatment of cardiovascular (CVS) and Central Nervous System (CNS) diseases. Scienture LLC launched its first commercial product for hypertension and is in the process of commercializing its second product for the treatment of opioid overdose. Its development pipeline consists of a broad range of novel product candidates including new potential treatments for migraine, thrombosis, pain and other related disorders.